Saving changes...

Done

Error

2020 In Review: Landmark Hematology and Oncology Drug Approvals - TECHNICIAN

2020 In Review: Landmark Hematology and Oncology Drug Approvals - TECHNICIAN

2020 In Review: Landmark Hematology and Oncology Drug Approvals - TECHNICIAN

Bradi L. Frei, PharmD, MSc, BCOP, BCPS & Laura Roccograndi, PharmD
Bradi L. Frei, PharmD, MSc, BCOP, BCPS & Laura Roccograndi, PharmD
on behalf of Texas Society of Health-System Pharmacists

$15.00 $ 15.00 $ 15.00

$15.00 $ 15.00 $ 15.00

$ 15.00 15.00 15.00
15.00 $ 15.00 15.00 15.00
Normal Price: $15.00 $15.00

Review:

Launch date: 24 May 2021
Expiry Date:

Last updated: 24 May 2021

Reference: 197120

TIming: null

Maximum Attendees:

Places Left: 0

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

This one-hour webinar will review the new medications approved in 2020 for hematology and oncology treatments. Review landmark trial data and use case-based scenarios to evaluate the new drugs and efficacy in treatment use.

Objectives

Technician Objectives
• Identify new hematology/oncology medications approved by the FDA that are significant advances to practice in 2020.
• Discuss relevant indications, safety, and dosing of new medications.
• List the drug class the new medications belong to and similar existing medications.
Bradi L. Frei, PharmD, MSc, BCOP, BCPS & Laura Roccograndi, PharmD

Author Information Play Video Bio

Bradi L. Frei, PharmD, MSc, BCOP, BCPS & Laura Roccograndi, PharmD
on behalf of Texas Society of Health-System Pharmacists

Bradi L. Frei, PharmD, MSc, BCOP, BCPS
Professor, Department of Pharmacy Practice
University of the Incarnate Word, Feik School of Pharmacy
This speaker has no relevant conflicts of interest to disclose.

Laura Roccograndi, PharmD
PGY2 Oncology Pharmacy Resident
The University of Texas MD Anderson Cancer Center
This speaker has no relevant conflicts of interest to disclose.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 1.00 Hours -
    Exam Pass Rate: 75

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error